Zhongliu Fangzhi Yanjiu is a peer-reviewed chinese-language open-access journal published by Magazine House of Cancer Research on Prevention and Treatment in China, operating under an open-access model since 2008. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Zhongliu Fangzhi Yanjiu; refer to the journal's APC page for the current rate. Articles are released under the CC BY license (see other journals using this license).
Keywords
surgery, chemotherapy, radiotherapy, epidemiology, immunotherapy
At a glance
ISSN
- 1000-8578
Frequently asked questions
Is Zhongliu Fangzhi Yanjiu peer-reviewed?
Yes — Zhongliu Fangzhi Yanjiu operates a Peer review review process.
Does Zhongliu Fangzhi Yanjiu charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate.
What subjects does Zhongliu Fangzhi Yanjiu publish?
Zhongliu Fangzhi Yanjiu publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Zhongliu Fangzhi Yanjiu accept?
Zhongliu Fangzhi Yanjiu accepts manuscripts in Chinese.
What is the ISSN of Zhongliu Fangzhi Yanjiu?
ISSN:
1000-8578 (print).How do I submit a manuscript to Zhongliu Fangzhi Yanjiu?
Submit through the journal's official portal: visit submission page →